Tag: Viking Therapeutics

Shares of Viking Therapeutics experienced a significant rally in today's trading session, marking a notable recovery after a volatile period ...

Shares of Viking Therapeutics have posted significant gains, fueled by renewed takeover speculation within the obesity drug sector. This sentiment ...

Shares of Viking Therapeutics closed the week on a strong note, propelled by emerging challenges facing a major competitor in ...

Shares of Viking Therapeutics experienced a significant surge this week, driven by a series of strategic updates and a notable ...

Shares of Viking Therapeutics, a clinical-stage biotechnology firm, experienced a significant rally, closing at $34.34 with a gain of approximately ...

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week. Positive clinical development ...

Shares of Viking Therapeutics gained approximately 2.9% to $36.42 following a pivotal regulatory decision that is reshaping the market for ...

A prominent analyst at investment bank H.C. Wainwright has reiterated a bullish stance on Viking Therapeutics, setting a price target ...

The competitive landscape for obesity treatments is heating up, fueling speculation about potential industry consolidation. At the center of this ...

Shares of Viking Therapeutics are currently trading within a narrow band between $35 and $36, continuing a period of consolidation ...